Abstract
BACKGROUND: Corifollitropin alfa is a new recombinant fertility hormone that is able to initiate and sustain follicular growth for an entire week and replaces seven daily injections of gonadotropins. Accordingly, this is a further improvement of the simplified, patient-centered GnRH antagonist regimen. The development program of corifollitropin alfa consisted of several trials that showed that the drug was safe and efficacious in terms of the number of oocytes obtained and ongoing pregnancy rates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
